Invention Grant
- Patent Title: Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof
-
Application No.: US15363832Application Date: 2016-11-29
-
Publication No.: US10436785B2Publication Date: 2019-10-08
- Inventor: Fernando Jose Rebelo do Couto , Zhiming Liao , Yifei Zhu
- Applicant: Spring BioScience Corporation
- Applicant Address: US CA Pleasanton
- Assignee: Spring BioScience Corporation
- Current Assignee: Spring BioScience Corporation
- Current Assignee Address: US CA Pleasanton
- Agency: Ventana Medical Systems, Inc.
- Main IPC: G01N33/573
- IPC: G01N33/573 ; C07K16/40 ; C12N9/02 ; C12N9/96 ; G01N33/574
Abstract:
The invention provides antibodies that bind specifically to human indoleamine 2,3-dioxygenase 1 (IDO1), and methods of using the same. The antibodies are capable of binding to a sequence comprising SEQ ID NO: 1 and specifically bind to human IDO1 in formalin fixed paraffin embedded tissues. The antibodies are useful in a number of different analytical techniques, including immunohistochemistry (IHC) and immunocytochemistry (ICC).
Public/Granted literature
- US20170146535A1 ANTI-INDOLEAMINE 2,3-DIOXYGENASE 1 ANTIBODIES AND DIAGNOSTIC USES THEREOF Public/Granted day:2017-05-25
Information query
IPC分类:
